These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24073274)

  • 61. Nanoscale imaging of CD47 informs how plasma membrane modifications shape apoptotic cell recognition.
    Dufour S; Tacnet-Delorme P; Kleman JP; Glushonkov O; Thielens N; Bourgeois D; Frachet P
    Commun Biol; 2023 Feb; 6(1):207. PubMed ID: 36813842
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site.
    Subramanian S; Boder ET; Discher DE
    J Biol Chem; 2007 Jan; 282(3):1805-18. PubMed ID: 17098740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-SIRP
    Yanagita T; Murata Y; Tanaka D; Motegi SI; Arai E; Daniwijaya EW; Hazama D; Washio K; Saito Y; Kotani T; Ohnishi H; Oldenborg PA; Garcia NV; Miyasaka M; Ishikawa O; Kanai Y; Komori T; Matozaki T
    JCI Insight; 2017 Jan; 2(1):e89140. PubMed ID: 28097229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma.
    Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D
    Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts.
    Theocharides AP; Jin L; Cheng PY; Prasolava TK; Malko AV; Ho JM; Poeppl AG; van Rooijen N; Minden MD; Danska JS; Dick JE; Wang JC
    J Exp Med; 2012 Sep; 209(10):1883-99. PubMed ID: 22945919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.
    Fortin G; Raymond M; Van VQ; Rubio M; Gautier P; Sarfati M; Franchimont D
    J Exp Med; 2009 Aug; 206(9):1995-2011. PubMed ID: 19703989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
    Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
    Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD47-SIRP
    Catalán R; Orozco-Morales M; Hernández-Pedro NY; Guijosa A; Colín-González AL; Ávila-Moreno F; Arrieta O
    J Immunol Res; 2020; 2020():9435030. PubMed ID: 33015199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biomimetic Design of Peptide Inhibitor to Block CD47/SIRPα Interactions.
    Zheng S; Ji Y; Li N; Zhang L
    Langmuir; 2023 Dec; 39(49):18101-18112. PubMed ID: 38038444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
    Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
    J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.
    McLaughlin KM; Bojkova D; Kandler JD; Bechtel M; Reus P; Le T; Rothweiler F; Wagner JUG; Weigert A; Ciesek S; Wass MN; Michaelis M; Cinatl J
    Curr Issues Mol Biol; 2021 Sep; 43(3):1212-1225. PubMed ID: 34698067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
    Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
    J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Engineered CD47 protects T cells for enhanced antitumour immunity.
    Yamada-Hunter SA; Theruvath J; McIntosh BJ; Freitas KA; Lin F; Radosevich MT; Leruste A; Dhingra S; Martinez-Velez N; Xu P; Huang J; Delaidelli A; Desai MH; Good Z; Polak R; May A; Labanieh L; Bjelajac J; Murty T; Ehlinger Z; Mount CW; Chen Y; Heitzeneder S; Marjon KD; Banuelos A; Khan O; Wasserman SL; Spiegel JY; Fernandez-Pol S; Kuo CJ; Sorensen PH; Monje M; Majzner RG; Weissman IL; Sahaf B; Sotillo E; Cochran JR; Mackall CL
    Nature; 2024 Jun; 630(8016):457-465. PubMed ID: 38750365
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure of the human marker of self 5-transmembrane receptor CD47.
    Fenalti G; Villanueva N; Griffith M; Pagarigan B; Lakkaraju SK; Huang RY; Ladygina N; Sharma A; Mikolon D; Abbasian M; Johnson J; Hadjivassiliou H; Zhu D; Chamberlain PP; Cho H; Hariharan K
    Nat Commun; 2021 Sep; 12(1):5218. PubMed ID: 34471125
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.
    Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deletion of CD47 from Schwann cells and macrophages hastens myelin disruption/dismantling and scavenging in Schwann cells and augments myelin debris phagocytosis in macrophages.
    Gitik M; Elberg G; Reichert F; Tal M; Rotshenker S
    J Neuroinflammation; 2023 Oct; 20(1):243. PubMed ID: 37872624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation.
    Dehmani S; Nerrière-Daguin V; Néel M; Elain-Duret N; Heslan JM; Belarif L; Mary C; Thepenier V; Biteau K; Poirier N; Blancho G; Haspot F
    Front Immunol; 2021; 12():732530. PubMed ID: 34925315
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The CD47-SIRPα axis is a promising target for cancer immunotherapies.
    Hao Y; Zhou X; Li Y; Li B; Cheng L
    Int Immunopharmacol; 2023 Jul; 120():110255. PubMed ID: 37187126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.
    Wang H; VerHalen J; Madariaga ML; Xiang S; Wang S; Lan P; Oldenborg PA; Sykes M; Yang YG
    Blood; 2007 Jan; 109(2):836-42. PubMed ID: 17008545
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD47-SIRPα Controls ADCC Killing of Primary T Cells by PMN Through a Combination of Trogocytosis and NADPH Oxidase Activation.
    Gondois-Rey F; Miller T; Laletin V; Morelli X; Collette Y; Nunès J; Olive D
    Front Immunol; 2022; 13():899068. PubMed ID: 35795660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.